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INTRODUCTION
The continuous discovery of new vaccines and therapeutics asks for the development of efficient systems for the production of pharmaceutical proteins. The choice of an appropriate host and suitable production conditions is crucial for the downstream processing of a pharmaceutical-grade product. Escherichia coli and members of the species Bacillus are the most frequently used prokaryotes for the industrial production of recombinant proteins. These organisms are above all favoured due to the fact that the cultivation of these bacteria in large-scale production systems at high cell densities is easy and usually inexpensive.
For the economical production of recombinant proteins, the existence of stable expression systems is a necessity. At present, about 60 % of the commercially available enzymes are produced by Bacillus species, mostly being homologous proteins that are naturally secreted in the growth medium, such as alkaline proteases as washing agent or amylases for the starch industry (Palva, 1982; Simonen and Palva, 1993; Schweder and Jurgen, 2001; Quax, 2003) . However, E. coli is still the most commonly used host for industrial production of pharmaceutical proteins as it is genetically most accessible and therefore first choice in the lead finding phase of a drug development project. Despite the fact that other systems may be superior to E. coli both in quality and efficiency, time pressure often has been prohibiting the change from host organism in later stages of development. In this review, we will address the considerations one may have in choosing the best cell factory for pharmaceutical proteins and the efforts that have been employed during the last years to improve B. subtilis as protein secretion factory.
In contrast to the well-known Gram-negative bacterium E. coli, the Grampositive bacterium B. subtilis is considered as a GRAS organism (generally recognised as safe). For that reason, the use of B. subtilis for the production of food products is highly favoured over the use of E. coli. The outer cell membrane of most Gram-negative bacteria, e.g. E. coli, contains lipopolysaccharides (LPS), generally referred to as endotoxins, which are pyrogenic in humans and other mammals. These endotoxins complicate product purification, because the end-product should be completely endotoxin-free (Petsch and Anspach, 2000; Bredmose et al., 2001) . Furthermore, in comparison to E. coli, B. subtilis is a more attractive host because it has a naturally high secretory capacity and exports proteins directly into the extracellular medium (Simonen and Palva, 1993) . The secretion of target proteins leads to a natural separation of the product from cell components, simplifying downstream processing of the protein. In addition, it may provide better folding conditions compared to the reducing environment in the cytoplasm (Moks et al., 1987) , thereby preventing the formation of inclusion bodies. Despite these clear shortcomings of the E. coli system, the use of the highly efficient Bacillus secretion hosts has remained limited to bulk industrial enzyme production. Although nearly 80 recombinant protein therapeutics have been approved worldwide (58 approvals in the US) (Reichert and Paquette, 2003) , none of these is produced in Bacillus. Besides the fact that there is no track record for pharmaceutical registration, the major reservations for using Bacillus have been (1) lack of suitable expression vectors; (2) plasmid instability; (3) presence of proteases; (4) occurrence of malfolded proteins. These shortcomings have been studied in detail in recent years and we will exemplify some solutions that have been brought forward by discussing recent attempts to express human pharmaceutical proteins in Bacillus. Table 1 lists an overview of the (protein) products that are successfully produced by B. subtilis, which should be representative for the range of products that can be produced in B. subtilis. There are no data available on the bioactivity.
In the past, the optimisation of protein production by bacterial strains was performed by empirical approaches, like studying the effects of medium compositions on protein production yields (Priest, 1989; Zukowski, 1992) . However, the introduction of the recombinant DNA technology has allowed a more directed intervention into the genetics of the production hosts. Overproduction of recombinant proteins has turned out to be a complex process Schematic representation of processes that affect the yield of heterologous proteins Although proteins can be produced intracellularly, this always runs the risk for inclusion body formation when the protein is highly overexpressed. Often extracellular production is chosen using protease-deficient strains to minimise proteolytic degradation. and designing improved production strains requires a comprehensive understanding of the cellular physiology of the cells under overproducing conditions. The choice of a promoter in combination with a DNA vector may work for the overexpression of one protein, but that does not guarantee highlevel production of other proteins. To broaden the range of proteins that can be produced in B. subtilis, more knowledge on cellular functions and development of better production systems is still needed.
EMPERICAL APPROACHES FOR PRODUCTION STRAIN OPTIMISATION
The Bacillus secretory pathway can be divided into three functional stages: (1) early stages involving the synthesis of secretory pre-proteins, their interaction (if any) with chaperones and binding to the translocase; (2) translocation across the cell membrane via the Sec (protein secretion of unfolded proteins) or Tat translocase (twin-arginine translocation of folded proteins); (3) late stages, including removal of the signal peptide, release from the translocase, folding on the trans side of the cell membrane and passage through the cell wall (Simonen and Palva, 1993; Braun et al., 1999; van Wely et al., 2001) . Thus, several different factors are involved before the produced protein reaches its final destination and conformation and therefore each of these factors can be a bottleneck for high-level production (Fig. 1 ). For production of heterologous proteins in the medium of B. subtilis, it is necessary to use a signal peptide that directs the protein very efficiently to the translocase and that is cleaved efficiently by the signal peptidases (van Roosmalen et al., 2004) . Therefore, modulation of a signal peptide to obtain an efficient signal peptidase cleavage site is sometimes a necessity (Quax et al., 1993) . Not only on the signal peptides themselves an extensive amount of work has been done, also several fusions have been made with heterologous proteins (Palva et al., 1982; Ohmura et al., 1984; Yamane et al., 1984; Fahnestock and Fisher, 1986; Fahnestock et al., 1986; Vasantha and Thompson, 1986; Wong and Doi, 1986; Nakamura et al., 1989; von Heijne and Abrahmsen, 1989; Borchert and Nagarajan, 1991; von Heijne, 1998) . Furthermore, an increased expression of signal peptidases could enhance the capacity of the secretion machinery, e.g. for AmyQ as shown by Tjalsma et al. (1998) and Pummi et al. (2002) .
Construction of B. subtilis strains with reduced protease activity
The high quality of the secreted proteins that are produced industrially is, at least in part, due to the presence of cellular "quality control" systems that efficiently remove incompletely synthesised or misfolded proteins. Because the folding of many heterologous proteins is usually inefficient, these quality control systems paradoxically represent major bottlenecks for the production of these heterologous proteins, the greatest problem being proteolytic degradation. A search in the SubtiList database (http://genolist.pasteur.fr/SubtiList/) for proteases and peptidases revealed the presence of 24 known and 6 putative proteases and 20 known and 21 putative peptidases. The known proteases and peptidases are partly depicted in Fig. 2 . Thus far, most attempts to find solutions were focused on the proteases that are secreted into the growth medium. The deletion of only two major extracellular proteases already declines the proteolytic activity tremendously and improves protein production yields (Ferrari et al., 1993) . Examples of protease-deficient strains that are mentioned below are listed in Table 2 . B. subtilis strains with deletions in the aprE (encoding subtilisin, alkaline protease E) and nprE (encoding neutral protease A) genes were the first reported in the same issue of the Journal of Bacteriology in 1984 to produce very low extracellular protease activity (Kawamura and Doi, 1984; Yang et al., 1984) . The BG2054 strain was tested on protease activity after growth in minimal media supplemented with casein hydrolysate, using azocoll as a substrate in the assay. No protease activity could be detected with this assay. The DB104 and DB105 strains were tested on Schaeffer sporulation agar plates with skim milk, resulting in protease activities of 2.6 % and 4.1 % compared to the parental strain (Kawamura and Doi, 1984; Stahl and Ferrari, 1984; Fahnestock and Fisher, 1987; Rufo et al., 1990) . Also a deletion mutation in the epr (encoding extracellular protease) gene resulted in a low protease activity in the culture supernatant (Sloma et al., 1988; Wang et al., 1989) . Since then, strains containing deletion mutations in multiple extracellular proteases have been constructed with extracellular protease activity of less than 0.5 % compared to the parental strain (Sloma et al., 1991; Wu et al., 1991) . These multiple deletion strains allow the production of proteins that are highly sensitive to protein degradation in the parental strain. It has to be noted that when protease activity levels are measured using different substrates under different conditions, it is difficult to compare the outcomes. In a neutral environment, e.g. alkaline proteases are not fully active (Gupta et al., 2002) . Furthermore, it has to be mentioned that inactivation of proteases leads to more cell lysis, which starts already at the point of transition from the exponential to the post-exponential growth phase. Occurrence of intracellular proteases in the medium caused by cellular lysis may result in lower production yields because of degradation of the protein of interest (Stephenson et al., 1999) . nprR2; nprE18; ∆aprA3 nprE; aprE; epr; bpr; isp I; isp II nprE; nprB; aprE; epr; mpr; bpf Kawamura and Doi, 1984 Jones and Quax, 1998 Wu et al., 1991 nprB; aprE; epr; mpr; bpf; vpr Ye et al., 1996 LB700 nprE; nprB; aprE; epr; mpr; bpf; wprA Lee et al., 2000 WB800 nprE; nprB; aprE; epr; mpr; bpf; vpr; wprA Wu et al., 2002 In a six-extracellular-protease-deficient strain, WB600 ( Fig. 2) , it was shown that protein degradation is minimised and the production yield of e.g. β-lactamase (Wu et al., 1991) , streptokinase (Wong et al., 1994) , and the antidigoxin single-chain antibody fragment (5 mg/l in shake flask culture; Wu et al., 1993) is improved compared to the production yields in the wild-type strain. With the inactivation of seven known extracellular proteases in the WB700 strain (Ye et al., 1999) (Fig. 2) , about 0.15 % of the wild-type extracellular protease activity could still be detected when these cells were cultivated for 24 h in super-rich medium. Serine protease inhibitors could inhibit this residual activity. The blood-clot dissolving agent staphylokinase (337 mg/l in a fermentor; Ye et al., 1999) and human Interleukin-3 (3 mg/l; Chapter 3, Westers et al., 2006) are successfully produced in this strain.
Although the presence of an eighth extracellular protease gene in B. subtilis could not be excluded at that time (April 1996) , it was thought that the residual serine protease activity of WB700 originated from intracellular proteases that were released into the medium through cell lysis. The cytoplasmic Lon protease of E. coli is a serine protease, which is known to be involved in the degradation of abnormal or foreign proteins. The Lon homologue in B. subtilis (LonA; Fig. 2 ) was inactivated in WB700 to investigate if LonA was active in the growth medium and thus responsible for the residual protease activity. However, inactivation of LonA did not reduce the extracellular protease activity and is therefore not involved in degradation of secretory proteins (Ye et al., 1996) .
In December 1996 an eighth extracellular protease was reported, named WprA (wall protease A; Fig. 2 ) (Margot and Karamata, 1996) . This cell wallassociated protease was shown to be involved in the degradation of secretory proteins prior to release into the culture medium. Unlike other protease genes, which are induced after the transition from the exponential to the postexponential growth phase, the wprA gene is expressed constitutively in exponentially growing cells and upregulated during the post-exponential phase (Stephenson and Harwood, 1998) . When the cell wall protease WprA was inactivated in the WB600 strain, the production of staphylokinase was enhanced compared to the parental strain, although the production levels were lower than those of the WB700 strain, presumably because of different culturing conditions. Stability tests of staphylokinase and streptokinase in spent medium of this strain, LB700, and the strains DB431 (four extracellular proteases inactivated) and WB600 revealed that both enzymes are much more stable in spent medium of LB700, although staphylokinase is more stable than streptokinase (Lee et al., 2000) . Inactivation of WprA in the WB700 strain led to an even better production system (B. subtilis WB800), although in some cases the growth temperature had to be lowered to 30 ºC to prevent inclusion body formation. Even after growing the cells for 48 h, no degradation of the protein of interest (cellulase) was shown (Murashima et al., 2002) . For production of staphylokinase-hirudin, an artificial heterodimeric protein with thrombolytic and anti-thrombotic activity, the strains WB600, WB700 and WB800 (Table 2) were tested. Both proteins are joined together via a leucine zipper that acts as a heterodimerisation domain. For purification purposes, staphylokinase was fused to a lysine-rich domain, whereas hirudin was coupled to a glutamate-rich domain. Production of staphylokinase and hirudin was performed separately and for the first, inactivation of the wprA gene in the WB800 strain improved the yield of intact protein dramatically, whereas production of the latter was the same for all strains. In the strains WB600 and WB700 degradation occurs mainly within the lysine-rich domain of the staphylokinase fusion judged from the molecular masses of the degradation products. This suggests that WprA cleaves lysinerich sequences (Lian et al., 2003) .
To overproduce and secrete human proinsulin (PI), a different approach was used (Olmos-Soto and Contreras-Flores, 2003) . In the DB431 strain (lacking four extracellular and two intracellular proteases) an aprE::PI transcriptional-translational fusion was introduced, in which not only the regulatory region of aprE but also the sequence coding for the signal peptide is used to achieve optimal secretion of the proinsulin. After introduction of the hpr2 (hpr encodes a transcriptional repressor of sporulation and extracellular protease genes) and degU32 (degU encodes a two-component response regulator involved in degradative enzyme and competence regulation) mutations, the resulting strain was called BB81.3. These mutations have a positive effect on the transcription of aprE, and thus on the aprE::PI fusion (Martinez et al., 1997; Olmos-Soto and Contreras-Flores, 2003) . The supplemented mineral medium used in this expression system induced the aprE promoter throughout the exponential phase, which resulted in a production level of 1 g/l of PI in a fermentor.
These studies prove that the gained knowledge on the Bacillus proteases leads to still further optimisation of production systems for heterologous proteins.
Coproduction of chaperones
For secretory production of the antidigoxin single-chain antibody (scFv) in B. subtilis (see also Section 2.1), the formation of inclusion bodies was found to be a limiting factor (Wu et al., 1993) . Analysis of the distribution of the protein showed that the secreted fraction represents only 23 % of the total scFv fragments produced by the cell. Therefore, strains were constructed producing molecular chaperones to increase the secretory production of the scFv, following the same approach as for E. coli (Lee and Olins, 1992; Dale et al., 1994; Thomas and Baneyx, 1996) . Like in E. coli, B. subtilis has the GroE and the DnaK series of intracellular molecular chaperones. The genes for these chaperones are organised in two operons, the groE operon (groES-groEL) and the dnaK operon (hrcA-grpE-dnaK-dnaJ-yqeT-yqeU-yqeV) (Li and Wong, 1992; Homuth et al., 1997) http://www.genolist.pasteur.fr/SubtiList/). From studies in E. coli, it has been known that these series of molecular chaperones can act either independently or synergistically in a consecutive manner to facilitate the folding and assembly of certain proteins (Gragerov et al., 1992; Langer et al., 1992a and b; Fenton and Horwich, 1997) . The two operons are both regulated by the repressor HrcA. When hrcA is inactivated, the intracellular molecular chaperones from the two operons are constitutively produced (Zuber and Schumann, 1994; Yuan and Wong, 1995a and b) . Overproduction of the antidigoxin scFv in the six-extracellular-protease-deficient B. subtilis strain WB600 in which hrcA is inactivated results in an increased secretion of the scFv (8 mg/l) compared to the parental strain (5 mg/l). Furthermore, less scFv aggregated in the intracellular insoluble fraction, whereas the total amount of produced scFv was the same. The lipoprotein PrsA is an extracytoplasmic molecular chaperone (Kontinen et al., 1991; Jacobs et al., 1993) which is bound to the outer surface of the cell membrane and is suggested to mediate protein folding at the late stage of secretion. Overproduction of both the foldase PrsA and the scFv led to an increase in the total amount of scFv. In both the secreted fraction (8.1 mg/l) and the intracellular soluble fraction (14 mg/l, compared to 3.7 mg/l for the parental strain), more scFv was present. Coproduction of both intracellular and extracytoplasmic molecular chaperones also led to a significant decrease of insoluble scFv (1.7 mg/l, compared to 13 mg/l for the parental strain). The total amount of produced scFv was increased 1.3x, but 2.5x more scFv was secreted (12.5 mg/l), and almost 4x more scFv was present in the intracellular soluble fraction (compared to the parental strain), predominantly in the mature form (Wu et al., 1998) . Inactivation of hrcA and overproduction of PrsA in the WB800 strain also result in drastic improvement of the production level of a fibrin-specific scFv (10-15 mg/l) compared to the WB700 strain, which has the same mutations. Looking at the contribution of each mutation in the WB800 strain to the increased production level, it can be concluded that this result was primarily caused by inactivation of hrcA and to a less extent by overproduction of PrsA (Wu et al., 2002) .
It has been shown that different chimeric α-amylases, which were built from AmyL (from Bacillus licheniformis), AmyQ (from Bacillus amyloliquefaciens), and AmyS (from Bacillus stearothermophilus), were produced at a lower level than wild-type α-amylase. These mutants had different isoelectric points and were constructed to study the influence of the charge of a secreted protein on passage through the negatively charged cell wall of B. subtilis. The chimeric α-amylases were shown to be stable in the growth medium and lower production levels were thought to be due to degradation in a cell-associated location, possibly before or during posttranslocational folding into their native conformations (Jensen et al., 2000) . These observations indicate that when mutagenesis is performed in a protein, this can lead to changed charges in the protein, which can result in lower production levels. Similarly heterologous proteins that exhibit a slower folding in the cell wall microenvironment may be prone to degradation. In those cases the folding of the proteins may need special attention. In a B. subtilis mutant named prsA3, the gene encoding the foldase PrsA contains a point mutation. Subtilisin-alkaline phosphatase fusion proteins have been shown to be degraded extensively in this strain. Presumably, this degradation occurs because the limited amounts of PrsA in this strain reduce the rate at which the fusion proteins are folded (Jacobs et al., 1993) . When an increased amount of PrsA is introduced by overexpression, the secretion of α-amylases and a protease is increased six-to twofold, respectively, when expressed at high levels (Kontinen and Sarvas, 1993) . A positive effect on the production of AmyL when the amyL gene is expressed at high rates from a multicopy plasmid has been described in more detail by C.L. Jensen in her thesis (1997) . The increased AmyL accumulation coincides with a strong reduction in degradation of newly synthesised AmyL in the PrsAoverexpressing strain, indicating that co-or posttranslocational folding is an important factor for efficient secretion. This suggests that the PrsA protein is the rate-limiting component of the secretion machinery, a finding that is of considerable biotechnological interest.
Production of recombinant protective antigen (rPA) from Bacillus anthracis, which is used in vaccines against anthrax, was tested in different host organisms. B. subtilis turned out to be the best candidate, although even when the WB600 strain was used, the half-life of rPA was only 12 h in spent medium due to residual proteolytic activity. To reduce the proteolytic degradation of rPA, which was thought to occur just after emerging from the translocase, the microenvironment on the trans side of the cytoplasmic membrane was adapted. Because the native structure of rPA contains a Ca 2+ ion, it is likely that metal ions also are important for the folding of this protein (Petosa et al., 1997 , and Mg 2+ are concentrated near the cell membrane/wall microenvironment due to D-alanylation of the wall and lipoteichonic acids. These ions serve as folding factors for several secreted proteins. By decreasing the D-alanylation of the cell wall, the density of negative charges in the wall increases, which in turn would increase the rate of protein folding (Hyyryläinen et al., 2000) . The D-alanylation of the teichoic acids in the cell wall in B. subtilis is regulated by the proteins encoded by the dlt-operon (dltA-dltE). The expression of the operon was placed under control of an inducible promoter, which makes it possible to decrease D-alanylation when the operon is not induced. Indeed, the yield of secreted rPA was significantly increased in this situation (Thwaite et al., 2002) .
Thiol-disulphide oxidoreductases
For the activity and stability of many exported heterologous proteins, disulphide bond formation is one of the most important processes. The formation of disulphide bonds in vivo is a fast and effective process, which is catalysed by thiol-disulphide oxidoreductases (Joly and Swartz, 1994) . In E. coli, disulphide bonds are formed in the periplasm, because the cytoplasm is too reducing for this process. In this organism, six thioldisulphide oxidoreductases have been found, DsbA-E and DsbG (Bardwell et al., 1991 and 1993; Kamitani et al., 1992; Missiakas et al., 1993 Missiakas et al., , 1994 Missiakas et al., , and 1995 Thony-Meyer et al., 1995; Andersen et al., 1997) . For expression of heterologous proteins in E. coli, commercially available systems are designed to circumvent formation of insoluble aggregates or ''inclusion bodies'' in the cytoplasm by fusing the gene of interest with dsbA (Collins-Racie et al., 1995) or with the gene encoding thioredoxin, trxA (LaVallie et al., 1993) . As fusion proteins with DsbA or TrxA, many troublesome proteins can be made in soluble forms that are biologically active. Hence, the solubility and accumulation level of heterologous proteins synthesised in the E. coli cytoplasm can be dramatically increased. In Bacilli and other Gram-positives, very little is known about disulphide bond formation and isomerisation. In these organisms the presence of thioldisulphide oxidoreductases was questioned for a long time, because their secreted proteins were not found to contain disulphide bridges and the formation of disulphide bonds in secreted heterologous proteins occurred very inefficiently (Bolhuis et al., 1999a) . However, recently the secreted B. subtilis sublancin 168 was found to contain two disulphide bonds of which the formation most likely involves the action of thiol-disulphide oxidoreductases (Dorenbos et al., 2002; Sarvas et al., 2004) . The first characterised thiol-disulphide oxidoreductase from a Gram-positive eubacterium was the Bdb (Bacillus disulphide bond) protein of Brevibacillus choshinensis (formerly known as Bacillus brevis) (Ishihara et al., 1995) . The orthologue of this Bdb in B. subtilis is denoted BdbA and two orthologues of DsbB protein from E. coli in B. subtilis are denoted BdbB and BdbC (Bolhuis et al., 1999b) . These latter B. subtilis proteins functionally correspond to the well-characterised E. coli DsbB and DsbA proteins, which catalyse the formation of disulphide bonds in proteins in the periplasmic space (Erlendsson and Hederstedt, 2002) . While it is not clear whether BdbA is secreted or retained in the membrane, BdbB and BdbC are membrane proteins with four transmembrane segments, and their catalytic Cys residues are predicted to be exposed on the extracytoplasmic side of the membrane. BdbD has a predicted signal peptide and is the fourth thioldisulphide oxidoreductase that was identified. Disruption of the bdbA, bdbB, or bdbC genes showed that the absence of BdbB or BdbC, but not BdbA, resulted in the secretion of significantly reduced levels of the two disulphide bonds containing alkaline phosphatase (PhoA) of E. coli (Bolhuis et al., 1999b) . Thus, BdbB and BdbC, most likely by catalysing disulphide bond formation or isomerisation, promote extracytoplasmic protein folding.
A recent attempt to produce a staphylokinase fusion with the fibrin-targeting Kringle domain of human plasminogen in B. subtilis WB800 failed unfortunately, probably because of malfolded disulphide bridges in the Kringle domain. The fusion of the Kringle domain of plasminogen with staphylokinase will target staphylokinase to fibrin so that bleeding complications are prevented. To achieve production of an active fusion protein in Pichia pastoris, mutants of the protein had to be made to prevent N-glycosylation (Wu et al., 2003) . The heterodimeric protein staphylokinase-hirudin was designed to couple an antithrombotic protein to a thrombolytic agent (see also Section 2.1). After production of this protein in B. subtilis WB800, an in vitro treatment was necessary to reshuffle the disulphide bonds in hirudin (Lian et al., 2003) . So it is still a challenge to optimise Bacillus host strains in such a way that production of proteins for which correct folding is necessary for activity is possible.
More successful is the production of human epidermal growth factor (hEGF) in B. choshinensis. This protein-hyperproducing bacterium was reported to produce up to 20 g/l of endogenous proteins in the medium (Udaka, 1976) . After designing a host-vector system for this strain, hEGF as well as bacterial proteins were successfully produced and secreted using this system (Takagi et al., 1989; Ebisu et al., 1992 and 1996; Udaka and Yamagata, 1993) . However, since hEGF contains three disulphide bonds, also incorrectly folded hEGF was produced. Strikingly, it has been reported that incubation of a non-native hEGF multimer with resting B. choshinensis cells resulted in the conversion of nonnative to native hEGF. This was the first finding suggesting that these cells have a novel thiol-disulphide exchange system. Overexpression of Bdb did not affect this conversion activity (Miyauchi et al., 1999) . In a recent article, the cloning of the genes ccdA-catA, encoding oxidoreductases, and co-expression of these genes with hEGF have been reported. Recently, CcdA of B. choshinensis with an associated thiol-disulphide oxidoreductase was proposed to be a homologue of DsbD in E. coli, which transfers electrons to DsbC, a periplasmic protein disulphide isomerase (PDI) (Katzen and Beckwith, 2002; Katzen et al., 2002) . It is likely that CcdA/CatA functions in the same manner. The action of the CatA protein, which was purified from B. choshinensis culturing broth, on the conversion of non-native multimeric hEGF in a resting cell system resulted in a twofold enhancement in production of native hEGF. Coexpression of the CatA protein and hEGF by using two expression vectors promoted the production of native hEGF about 1.3x. This slight enhancement was probably caused by a decreased copy number of the plasmid with the gene encoding hEGF due to the coexistence of two plasmids (Miyauchi et al., 1999) .
The same trick has been performed earlier, using a fungal PDI, which was dicistronically expressed with the light chain (LC) of immunoglobulin G on an expression vector or as a fusion protein with the PDI at the N-terminus (Kajino et al., 2000) . Coexpression of LC with PDI did not give an improvement of LC expression (10 mg/l), but expression of the fusion protein led to LC amounts up to 150 mg/l. Even when the active site of PDI, Cys-X-X-Cys, was mutated to Ser-X-X-Ser, the expression level of the fusion protein was this high. This indicates that PDI, besides its function as disulphide bond isomerase, also functions as an important chaperone, thereby preventing protein aggregation.
CANDIDATE STRATEGIES FOR FURTHER OPTIMISATION OF PRODUCTION STRAINS
Now that the genomes of the important bacterial production hosts E. coli and B. subtilis have become transparent, we can get a more extensive picture of what is going on inside the cells by means of the 2D-PAGE and DNA-array techniques. Although many empirical approaches led to significantly improved host strains, these new techniques pave the way towards a scientific approach of strain improvements.
Transcriptional analysis and 2D-gel electrophoresis
It has been shown that E. coli responds to the strong overproduction of recombinant proteins by significantly increased mRNA levels of heat shock genes such as lon and dnaK and increased protein levels of the chaperones GroEL, DnaK, and Tig and decreased levels of ribosomal proteins (Jurgen et al., 2000) . Often accumulation of recombinant proteins results in the formation of inclusion bodies, to which host stress proteins like DnaK, GroEL, IbpA, IbpB and OmpT can be associated.
To study the cellular response to overproduction of PorA, an outer membrane protein from Neisseria meningitidis that forms cytoplasmic inclusion bodies when produced in B. subtilis (Nurminen et al., 1992) , the transcriptional pattern of the overproducing B. subtilis strain was compared with the nonproducing strain (Jurgen et al., 2001) . Using the DNA macro-array technique, the PorA overproducing strain showed increased mRNA levels from genes coding for the chaperones dnaK, groEL and grpE, the protease clpP and the ATPases clpC and clpX, whereas the mRNA levels of the two potential Lon proteases of B. subtilis (lonA and lonB) were not increased. Genes encoding purine and pyrimidine synthesis enzymes and ribosomal proteins showed the most clearly increased mRNA levels, which is not consistent with data from overexpression experiments in E. coli. Here strong overexpression showed a decrease in expression of ribosomal genes. In the paper of Jurgen et al. (2001) it is cautiously speculated that B. subtilis cells would be able to correct an imbalance in the availability of purines and pyrimidines and ribosomal proteins due to an increase of porA expression at the beginning of the stationary phase.
To compare the cytoplasmic protein pattern of PorA overproducing cells, soluble protein fractions from both the control and the overproducing strain were isolated and separated by 2D-PAGE. In the overproducing strain, protein levels of DnaK and GroEL were clearly increased. The protein levels of ClpP and ClpC were moderately increased. These data are consistent with the transcriptome analyses, although the differences are more pronounced. These results were confirmed by Western blot analyses, in which also the presence of PorA in inclusion bodies was shown. Furthermore, the level of the ribosomal proteins RpsB and RplJ was increased in the overproducing strain, whereas the pI of other ribosomal proteins was too high to analyse them in these experiments.
Association of ClpP, ClpC and ClpX to the inclusion bodies was shown by electron microscopy using immunogold labelling. These findings demonstrate that overproduction of heterologous proteins in Bacillus results in a cellular response that is similar to the heat shock-like response in E. coli. The major difference is the important role of the Clp-machinery of Bacillus in the degradation of heterologous proteins (Kruger et al., 2000) and the Lon proteases being offside.
Having these results, one can now go back to the more empirical approach and adjust the production system to obtain better production levels.
Genomics: minimising the genome
One of the key questions emerging from the still expanding data set of complete genome sequences is how many genes are essential for life of an organism such as B. subtilis. In a recent manuscript, only about 270 genes were shown to be indispensable for growth of B. subtilis in a rich medium at 37 ºC, which suggests that the majority of the B. subtilis genome would be dispensable for growth under defined conditions (Kobayashi et al., 2003) . For production of heterologous proteins, it may be beneficial to delete these parts of the genome. Any unnecessary gene product that is expressed in a production host represents a potential contaminant that could drive up the cost of product purification, certainly when drugs or vaccines must pass certification. Deletion of the gene coding for that side product is by far the most reliable and effective way to ensure the complete absence of an unwanted component in a biotechnological product (Kolisnychenko et al., 2002) . And by deleting parts of the genome, cellular metabolite and energy resources would not be spent to maintain and express the deleted genetic information. Thus, the metabolism would be optimally directed towards the synthesis of both essential and desired gene products. Furthermore, since fewer unwanted proteins are synthesised the metabolic waste might decrease. In the EU-project ''Bacillus Minimal Genome '' (Westers et al., 2003) , a sequential and cumulative approach was explored to delete large dispensable AT-rich regions from B. subtilis strain 168, aiming at improvement of the cell factory. Finally, the genome was reduced by 7.7 % by deleting two prophages (SPβ and PBSX), three prophage-like elements (prophage 1, prophage 3, and skin), and the polyketide synthase (pks) operon (Fig. 3) .
The results of the genome minimisation studies show that this genome engineering did not affect cell viability or the key physiological and developmental processes of B. subtilis. Analysis of the metabolic flux ratio (METAFoR) of parental and deletion strains revealed an almost identical intracellular carbon metabolism. Also competence, sporulation, and proteolytic activity were unaffected. Additionally, the secretion capacity of the ∆6 strain for overproduced AmyQ of B. amyloliquefaciens was the same for B. subtilis ∆6 and B. subtilis 168. This suggests that no large energy resources were redirected towards product formation. Furthermore, only few proteins are absent from the extracellular proteome, which indicates that the ∆6 strain is only marginally improved in terms of removal of unwanted byproducts. To what extent the ∆6 strain represents an improved bacterial cell factory remains to be tested. The B. subtilis ∆6 strain has one major advantage over conventional B. subtilis production strains: it lacks the BsuM restriction-modification system, which was found to be responsible for structural plasmid instability in B. subtilis, limiting the application potential of plasmids for high level protein production (Haima et al., 1987) . Because there is no ''serious harm'' done to the cells, further reduction still may lead to an improved lean Bacillus production machine, especially with regard to reducing unwanted byproducts in the growth medium that are above all inconvenient when a heterologous protein is not expressed and secreted at such high amounts as, e.g., AmyQ. 
Engineering the metabolism
The limit of the yield of a biotechnological product is influenced by the energetic household of the host organism. In studies upon the influence of the P-to-O ratio (amount of ATP produced per atom oxygen consumed) in B. subtilis on the maximum riboflavin yield, not only the bioenergetic efficiency was estimated, but also homology searches for respiratory chain components from E. coli were performed in the genome database of B. subtilis. This was done to see whether a logical explanation could be found for a lower P-to-O ratio in B. subtilis than the maximum value that is assumed for E. coli. For NADH dehydrogenase I (NDH-I), encoded by nuoA-N in E. coli, no B. subtilis analogue was found, indicating that B. subtilis lacks the energy-coupling NDH-I site. It was suggested that one strategy to engineer a B. subtilis strain with improved P-to-O ratio might be to functionally express nuoA-N from E. coli in B. subtilis. Over-production of riboflavin biosynthesis components will not improve the yield, because in bacteria the carbon consumption rate is correlated with the growth rate and thus with biomass formation (Sauer and Bailey, 1999) .
For production of two pharmaceutical human proteins, the human leukocyte interferon (IFN-α 1 ) , an important therapeutic protein used as an anti-viral and anti-cancer agent, and erythropoietin (EPO), used for the treatment of anaemia, the metabolic fluxes in the B. licheniformis were analysed theoretically. The metabolic reaction network of B. licheniformis contains 105 metabolites and 147 intracellular reactions (Calik and Ozdamar, 1999) . The influence of different carbon sources (glucose and citrate) on this intracellular metabolic reaction network during production of IFN-α 1 and EPO was investigated to reveal the potential metabolic bottlenecks in the synthesis of these proteins. Using this strategy, it was possible to pinpoint candidate metabolic engineering sites. When glucose is used as a carbon source, the glycolysis, the pentose phosphate pathway (PPP), and the tricarboxylic acid (TCA) cycle are active, whereas the gluconeogenesis pathway is inactive, as expected. The fluxes towards the amino acid synthesis pathways are higher with glucose. In the case of citrate, the glycolysis pathway and the reaction from oxaloacetate to citrate are inactive, but the gluconeogenesis pathway is active. The total generation rate of ATP is lower with citrate. According to the model, the highest yield of both IFN-α 1 and EPO would be achieved using glucose as carbon source. Moreover, the EPO synthesis capacity was expected to be 10 % lower than that of IFN-α 1 . Simply looking at the amino acid distribution in both proteins, it becomes clear that both proteins contain a large number of Leu residues. Therefore, the flux towards Leu would be an ''engineering site''. Because in the synthesis of Leu six enzymes are involved, encoded by the genes ilvB, ilvC, ilvD, leuA, leuCD, and leuB, these genes are candidates for metabolic engineering. Choosing a host strain with a high Leu uptake or synthesis rate may be another possibility. Since it has been reported that the Leu uptake rate is high in Bacillus pasteurii (Beck and Jahns, 1996) , this Bacillus strain seems to be a potential alternative to produce IFN-α 1 and EPO (Calik and Ozdamar, 2002) . Similar results were found in theoretical analyses of B. licheniformis producing a serine alkaline protease or α-amylase. In these cases, large amounts of Ala, Ser, Gly and Asn were needed (Calik and Ozdamar, 2001) .
